2 ms·
Yup, but running stability studies is also costly too, not so much for the testing, but for regulatory approvals - you need to write up the stability part again
by ekianjo 10y ago
Yup, but running stability studies is also costly too, not so much for the testing, but for regulatory approvals - you need to write up the stability part again, argue why the results are still acceptable in case you see any increase of degradation products, and pay a fee and wait 6 months to 1 year to get it approved, then enjoy paying again to relabel all your package, PIL, etc... that goes with it.
Most of the time, unless you had a realllllly short shelf life at submission timing, the additional work is not worth it for the pharma industry side. Resources are better used working towards new/pending products.